Exact Sciences Corp (EXAS) Tops Q3 EPS by 2c
Exact Sciences Corp (NASDAQ: EXAS) reported Q3 EPS of ($0.16), $0.02 better than the analyst estimate of ($0.18). Revenue for ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
